<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01615900</url>
  </required_header>
  <id_info>
    <org_study_id>BRD/11/06-O</org_study_id>
    <nct_id>NCT01615900</nct_id>
  </id_info>
  <brief_title>Randomized Open Label Study Evaluating the Coverage by Teleconsultation Versus Standard Follow-up of Renal Transplant Patients According to a Risk Score of Early Graft Failure (KTFS)</brief_title>
  <acronym>TELEGRAFT</acronym>
  <official_title>Randomized Open Label Study Evaluating the Coverage by Teleconsultation Versus Standard Follow-up of Renal Transplant Patients According to a Risk Score of Early Graft Failure (KTFS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to optimize the coverage of renal transplant patients
      thanks to a personalized follow-up based on a risk score of early graft failure (KTFS, Kidney
      Transplant Failure Score), associated with teleconsultations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 7, 2012</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of serious adverse events</measure>
    <time_frame>2 years</time_frame>
    <description>The main objective of this study is to optimize the coverage of renal transplant patients thanks to a personalized follow-up based on a risk score of early graft failure (KTFS, Kidney Transplant Failure Score), associated with teleconsultations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness of the personalized follow-up</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life linked to the health of transplant patients</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Renal Transplant Patient</condition>
  <arm_group>
    <arm_group_label>Teleconsultation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard consultation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Teleconsultation / Standard consultation</intervention_name>
    <description>Stage 1: randomization. Two arms: teleconsultation and standard consultation
Stage 2: calculation of Kidney Transplant Failure Score which will determine 4 sub-groups: teleconsultation high risk, teleconsultation low risk, standard consultation high risk and standard consultation low risk.
Stage 3: follow-up (2 years) according to the group:
Standard consultation low risk: consultation every 2 months during one year and then every 3 months during one year
Standard consultation high risk: consultation every 6 weeks during one year and then every 2 months during one year
Teleconsultation low risk: same follow-up as &quot;standard consultation low risk&quot; group but all the consultations are teleconsultations
Teleconsultation high risk: same follow-up as &quot;standard consultation high risk&quot; group but the follow-up will be intensified by the addition of an intermediate teleconsultation (between 2 consultations)</description>
    <arm_group_label>Teleconsultation</arm_group_label>
    <arm_group_label>Standard consultation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient

          -  Having received a deceased donor renal transplant one year ago

          -  Having an access internet high-speed

          -  Having a compatible computer and supporting the videoconference

          -  Calculable KTFS (Kidney Transplant Failure Score)

          -  Patient having participated in a therapeutic educational program

          -  Patient has given informed consent

          -  Patient insured

        Exclusion Criteria:

          -  Patient under age 18

          -  Patient having received a multi-organ transplant (heart kidney / liver kidney / kidney
             pancreas / lung kidney / heart lung kidney)

          -  Patient non-compliant

          -  BK virus nephropathy or BK positive viremia

          -  CMV positive viremia

          -  Identified and treated psychiatric disorders

          -  Participation in another clinical study

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aurélie MEURETTE, Dr</last_name>
    <phone>+33 2 40 08 74 35</phone>
    <email>aurelie.meurette@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lyon University Hospital</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurélie MEURETTE, Dr</last_name>
      <phone>+33 2 40 08 74 35</phone>
      <email>aurelie.meurette@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Aurélie MEURETTE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Necker Hospital / AP-HP</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2012</study_first_submitted>
  <study_first_submitted_qc>June 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2012</study_first_posted>
  <last_update_submitted>November 17, 2017</last_update_submitted>
  <last_update_submitted_qc>November 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Renal graft</keyword>
  <keyword>Teleconsultation</keyword>
  <keyword>Kidney transplant failure score</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

